Document:

Prepared by MERRILL CORPORATION

Exhibit 10.9

[BIOTRANSPLANT LOGO]

Building
75, 3rd Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel: 617/241-5200

Fax: 617/241-8780

July 30, 1991

Dr. Mary White-Scharf

19 Johnson Road

Winchester, MA 01890

Dear Mary:

This letter will confirm our offer to you
to join BioTransplant, Inc. on the following terms:

	Title:	Director
  of the Monoclonal Antibody Department reporting to the Vice President of
  Research and Development
	 	 
	Terms:	This
  offer is contingent on your starting on or before September 9, 1991.
	 	 
	Compensation:	$70,000
  per year
	 	 
	Equity:	To
  be determined by the Board of Directors
	 	 
	Agreements:	Your
  employment is subject to your signing a Confidentiality, Invention Agreement
  and a Non-Compete Agreement with BioTransplant and review of any agreement
  you may have with others to insure that your employment with BioTransplant is
  not in conflict with any such agreements.

If these terms are acceptable, please
sign and return one copy of this agreement.

We look forward to your joining the
company and sharing in our new challenge.

Best regards,

/s/ Bernice Schacter, Ph.D.

Bernice Schacter, Ph.D.

Vice President Research & Development

AGREED TO:

	By:
  	 /s/ Mary White-Scharf, Ph.D.	 	Date:	8/7/91
	 	

	 	 	

	 	Mary
  White-Scharf, Ph.D.	 	 	 

[BIOTRANSPLANT LOGO]

Building
75, 3rd Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel: 617/241-5200

Fax: 617/241-8780

March
31, 1996

Dr. Mary White-Scharf

14 Johnson Road

Winchester, MA 10890

Dear Mary:

             Reference
is made to the Letter Agreement dated July 30, 1991, by and between
BioTransplant Incorporated and you (the “Letter Agreement”).  The Letter Agreement is hereby amended to
add the following additional term:

	 	Severance:	In
  the event your employment is terminated without cause, you will receive up to
  6 months base salary, payable in 12 equal installments which will be
  discontinued upon your securing other employment.

             Please
sign below to acknowledge your agreement with the foregoing.

	 	Very
  truly yours,
	 	 
	 	/s/
  Elliot Lebowitz
	 	

	 	Elliot
  Lebowitz, Ph.D.
	 	President
  and Chief Executive Officer

AGREED:

	By:	/s/
  Mary White-Scharf
	 	

	 	Mary
  White-Scharf

Date: 
April 15, 1996Prepared by MERRILL CORPORATION

Exhibit 10.10

[BIOTRANSPLANT LOGO]

Building
75, 3rd
Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel: 617/241-5200

Fax: 612/241-8780

November 13, 1991

Richard V. Capasso

39 Rocky Nook

Malden, MA 02148

Dear Rick:

This letter will confirm our offer to you
to join BioTransplant, Inc. on the following terms:

	Title:	Controller
	 	 
	Terms:	This
  offer is contingent on your starting on or about December 9, 1991.
	 	 
	Compensation:	$65,000
  per year/six month review, no guarantee of salary increase.
	 	 
	Bonus:	Eligible;
  with a guaranteed minimum of $5,000 for 1992.
	 	 
	Equity:	10,000
  options; subject to approval by the Board of Directors.
	 	 
	Agreements:	Your
  employment is subject to your signing a Confidentiality, Invention Agreement
  and a Non-Compete Agreement with BioTransplant and review of any agreement
  you may have with others to insure that your employment with BioTransplant is
  not in conflict with any such agreements.

If these terms are acceptable, please
sign and return one copy of this agreement.

We look forward to your joining the
company and sharing in our new challenge.

Best regards,

/s/ Elliot Lebowitz

Elliot Lebowitz, Ph.D.

President and C.E.O

AGREED TO:

	By:  	/s/
  Richard V. Capasso	 	Date:	11/14/91
	 	

	 	 	

	 	Richard
  V. Capasso	 	 	 

 

[BIOTRANSPLANT LOGO]

Building
75, 3rd
Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel: 617/241-5200

Fax: 612/241-8780

March
31, 1996

Mr. Richard Capasso

10 Rolling Lane

Wayland, MA 01778

Dear Rick:

             Reference
is made to the Letter Agreement dated November 13, 1991, by and between
BioTransplant Incorporated and you (the “Letter Agreement”).  The Letter Agreement is hereby amended to
add the following additional term:

	 	Severance:	In
  the event your employment is terminated without cause, you will receive up to
  6 months base salary, payable in 12 equal installments which will be
  discontinued upon your securing other employment.

             Please
sign below to acknowledge your agreement with the foregoing.

	 	Very
  truly yours,
	 	 
	 	/s/
  Elliot Lebowitz
	 	

	 	Elliot
  Lebowitz, Ph.D.
	 	President
  and Chief Executive Officer

AGREED:

	By:	/s/
  Richard V. Capasso
	 	

	 	Richard
  V. Capasso

Date: 
April 15, 1996Prepared by MERRILL CORPORATION

Exhibit 10.11

[BIOTRANSPLANT LOGO]

Building
96, 13th
Avenue

Charlestown Navy Yard

Charlestown, MA 02129

Tel. 617/241-5200

Fax: 617/241-8780

June 29, 1992

James A. Hope, Ph.D.

146 Prospect Street

Hingham, MA

Dear James:

This will confirm our offer to you to
join BioTransplant, Inc. on the following terms:

	1.	Title:	Vice
  President of Development of BioTransplant, Inc. reporting to the President.
	 	 	 
	2.	Terms
  of Offer:	This
  offer is contingent on your starting employment on or by August 3, 1992.
	 	 	 
	3.	Compensation:	$125,000
  per year.  Bonus eligible.  $5,000 to be paid as a salary advance on
  the first day of employment.  Base
  salary for the first 12 months of employment remains at $125,000.
	 	 	 
	4.	Benefits:	Standard
  package, as provided by the company including life insurance at 1x salary,
  medical and dental insurance (85% of premium paid by company, 15% balance
  paid by employee), disability insurance, paid parking at the Charlestown Navy
  Yard, three (3) weeks paid vacation/personal time accrued on an annual basis,
  and 10 paid holidays per year.  The
  company will provide funds to cover COBRA benefits on existing health
  insurance until BTI coverage begins.
	 	 	 
	5.	Equity:	Option
  to purchase 100,000 shares of common stock granted at Fair Market Value,
  vested in equal installments over four (4) years beginning with the first
  anniversary of employment as determined by the Board.  Stock is subject to repurchase at cost and
  restriction on sale if terminated for cause. 
  Eligible for future stock options at the end of each year subject to
  the discretion of the Board.
	 	 	 
	6.	Severance:	In
  the event your employment is terminated by BioTransplant without cause, you
  would receive up to 6 months base salary, payable in 6 equal installment
  which would be discontinued upon your securing other employment.  If employment has not been secured after 6
  months, an additional severance payment of up to 6 months base salary would
  be negotiated.
	 	 	 
	7.	Agreements:	Your
  employment is subject to your signing a Confidentiality, Invention Assignment
  and Non-Compete Agreement with BioTransplant and review of any agreements you
  may have with others to insure that your employment by BioTransplant is not
  in conflict with any such agreements.

If these terms are acceptable, please
sign and return one copy of this agreement.

We are very enthusiastic about your
joining the company.

With best regards.

Sincerely,

/s/ Elliot Lebowitz

Elliot Lebowitz, Ph.D.

President and Chief Executive Officer

AGREED TO

	By:	/s/
  James A. Hope	 	Date:	7/6/92
	 	

	 	 	

	 	James
  A. Hope, Ph.D.Prepared by MERRILL CORPORATION

Exhibit 10.12

Effective as of May 15, 2001

Mr. Walter Ogier

433 Main Street

Winchester, MA  01890

Dear Walter:

I am writing to confirm our offer to you
for a position as President and Chief Operating Officer, reporting to Elliot
Lebowitz, Ph.D., Chief Executive Officer. 
We are pleased to offer you a starting salary of $20,130.00 per month
(equivalent to $241,560.00 per year), to be paid semi-monthly and reviewed
annually.  The monthly salary includes
an allowance to help offset contributions to certain benefits should you elect
them.  You are also eligible for an
annual cash bonus of 35% of base salary and to participate in our annual
merit-based stock option program, provided that any award of options will be
subject to the approval of our Board of Directors. You are also entitled to
receive shares of BTI common stock in accordance with the terms and conditions
of the Eligix, Inc. Management Equity Incentive Plan. In addition, you will
receive medical and dental insurance, 15% of the cost of which is contributed
by the employee.  Term life insurance,
equivalent to one times your annual salary, and parking will be provided by the
company without employee contribution. Long-term disability insurance is
provided, 100% of the cost is contributed by the employee (your annual premium
would be approximately $1,416.00).  You
will also be entitled to three weeks paid vacation accrued on an annual basis
and 11 paid holidays per year.  In the
event your employment is terminated by Biotransplant without cause, you would receive
up to 12 months double base salary, payable in 24 equal semi-monthly
installments, which would be discontinued upon your securing other employment.

Your employment is subject to your
signing an Invention, Non-Disclosure and Non-Compete Agreement with
BioTransplant, in the form previously provided to you, and review of any
agreement you may have with others to insure that your employment with
BioTransplant is not in conflict with any such agreements.

Also, this offer is contingent upon your
ability to provide proof of your legal right to work in the United States, as
defined by Federal regulations.

By signing this letter below, you
acknowledge that the foregoing offered terms of your employment with
BioTransplant do not constitute (i) a significant diminution of your duties,
responsibilities, power, title or office in effect at Eligix, Inc. immediately
prior to your acceptance of this offer or (ii) a material reduction in your
compensation (including without limitation, salary, bonuses, options and benefits)
or material change in your manner of compensation (including without
limitation, the timing of any salary or bonus payments) in effect for you at
Eligix, Inc. immediately prior to your acceptance of this offer.

If you agree to the terms outlined above,
please sign both copies of this letter and return one copy using the enclosed,
stamped envelope.

We look forward to your joining
BioTransplant. We are confident that you will make a significant contribution
to BioTransplant's future success.

Sincerely,

/s/ Elliot Lebowitz

Elliot Lebowitz, Ph.D.

President and CEO

Accepted and Agreed to:

	/s/
  Walter C. Ogier	 	 
	

	 	 
	Name:  Walter C. Ogier	 	Date:  May 15, 2001

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}]]